Oncology
From the Journals
Breast cancer surgery timing matters, but is faster always better?
There are no national quality metrics delineating optimal breast cancer surgery timing.
Latest News
HER2-low breast cancer is not a separate clinical entity: Study
Much attention has been focused recently on the idea that breast cancer with a low expression of HER2 can be treated with HER2-targeted agents,...
News from the FDA/CDC
FDA expands abemaciclib use in high-risk early breast cancer
The new expansion removes the Ki-67 testing requirement.
Conference Coverage
Atorvastatin cut anthracycline cardiac dysfunction in lymphoma
Latest News
Skin reactions from melanoma targeted and immune therapies range from pruritus to SJS
Appearance of vitiligo is regarded as a good prognostic factor in the treatment of melanoma with various checkpoint inhibitors alone or in...
From the Journals
Ovarian cancer risk lower with daily aspirin, despite genetics
Although promising for chemoprevention, aspirin use can also come with downsides.
Feature
Docs struggle to keep up with the flood of new medical knowledge. Here’s advice
The sheer number of new studies may even force some doctors to retreat from areas where they have not kept up, according to a physician professor...
From the Journals
Does CRC risk in IBD extend to close family members?
Extra screening for CRC may not be needed for children, siblings, or parents of those with IBD, new study findings suggest.
From the Journals
Colorectal cancer incidence doubled in younger adults
Diagnoses in people younger than 55 years doubled from 1995 to 2019.
From the Journals
Who’s at higher risk for breast cancer recurrence?
New research shows that patients with ER-negative disease have a higher risk of a second breast cancer within a 5-year window post diagnosis,...
From the Journals
Pancreatic cancer incidence increases among young women in U.S.
Additional studies are needed to investigate contributing factors, particularly race and tumor characteristics.